| Literature DB >> 32155955 |
Bojan Vujić1, Vera Vidaković2, Milka Jadranin3, Irena Novaković3, Snežana Trifunović1, Vele Tešević1, Boris Mandić1.
Abstract
Helichrysum plicatum DC. is widely used in folk medicine in treating a variety of health disorders. The aim of this study was to examine the influence of different extraction solvents on the chemical composition, antioxidant potential, and antimicrobial activities of H. plicatum. Aerial parts were separately extracted with ethanol, dichloromethane, and sunflower oil. The oil extract (OE) was re-extracted with acetonitrile. A total of 142 compounds were tentatively identified in ethanolic (EE), dichloromethane (DCME), and acetonitrile (ACNE) extracts using HPLC-DAD/ESI-ToF-MS. The dominant compound class in all extracts were α-pyrones, alongside flavonoids in EE, terpenoids in DCME and ACNE, and phloroglucinols in DCME. The antioxidant potential of the extracts was assessed by the 2,2-diphenyl-1-picrylhydrazyl radical (DPPH) assay. EE and DCME possessed the most potent radical scavenging capacity. Antimicrobial activity was investigated on eight bacterial, two yeast, and one fungal species. All extracts exhibited high antifungal and notable antibacterial activities compared to control substances, with DCME being the most potent. DCME exhibited stronger antimicrobial activity against P. aeruginosa than the standard chloramphenicol.Entities:
Keywords: Helichrysum plicatum; antimicrobial activity; antioxidant potential; liquid chromatography-mass spectrometry (LC-MS); phenols; solvent polarity
Year: 2020 PMID: 32155955 PMCID: PMC7154845 DOI: 10.3390/plants9030337
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Composition of H. plicatum ethanol (EE), dichloromethane (DCME), and acetonitrile oil (ACNE) extract analysed by HPLC-DAD/ESI-ToF.
| No | Compound Class/Name | EE | DCME | ACNE |
|---|---|---|---|---|
|
| ||||
|
| ||||
| 1 | 6-ethyl-4-hydroxy-5-methyl-3-(3-oxopentyl)-2H-pyran-2-one [ | + | ||
| 2 | micropyrone [ | + | ||
| 3 | micropyrone analog [ | + | ||
| 4 | helipyrone C [ | + | + | + |
| 5 | bisnorhelipyrone [ | + | ||
| 6 | plicatipyrone analog [ | + | ||
| 7 | 3,3’-methylenebis[4-(acetyloxy)-5,6-dimethyl-2H-pyran-2-one [ | + | ||
| 8 | helipyrone B [ | + | ||
| 9 | 3-[[3-acetyl-2,4,6-trihydroxy-5-(3-methyl-2-buten-1-yl)phenyl]methyl]-4-hydroxy-6-methyl-2H-pyran-2-one [ | + | ||
| 10 | plicatipyrone [ | + | + | + |
| 11 | arenol [ | + | + | + |
| 12 | plicatipyrone analog [ | + | ||
| 13 | arzanol [ | + | + | + |
| 14 | heliarzanol [ | + | + | |
| 15 | cycloarzanol [ | + | ||
| 16 | helipyrone diacetate [ | + | + | |
| 17 | methylarzanol [ | + | + | |
| 18 | 3-[1-[3-acetyl-2,4,6-trihydroxy-5-(3-methyl-2-buten-1-yl)phenyl]ethyl]-6-ethyl-4-hydroxy-5-methyl-2H-pyran-2-one [ | + | + | |
| 19 | auricepyrone [ | + | ||
| 20 | helicerastripyrone [ | + | ||
| 21 | 4-hydroxy-5,6-dimethyl-3-[[2,4,6-trihydroxy-3-(3-methyl-2-buten-1-yl)-5-(2-methyl-1-oxobutyl)phenyl]methyl]-2H-pyran-2-one [ | + | ||
| 22 | 3-[[3-acetyl-5-(3,7-dimethyl-2,6-octadien-1-yl)-2,4,6-trihydroxyphenyl]methyl]-4-hydroxy-5,6-dimethyl-2H-pyran-2-one [ | + | ||
| 23 | plicatipyrone analog [ | + | + | |
| 24 | 6-ethyl-4-hydroxy-5-methyl-3-[[2,4,6-trihydroxy-3-(3-methyl-2-buten-1-yl)-5-(2-methyl-1-oxopropyl)phenyl]methyl]-2H-pyran-2-one [ | + | + | |
| 25 | norauricepyrone [ | + | ||
| 26 | 3-[[2,4-dihydroxy-6-methoxy-3-(2-methyl-1-oxobutyl)phenyl]methyl]-6-ethyl-4-hydroxy-5-methyl-2H-pyran-2-one [ | + | ||
| 27 | 3-[1-[3-acetyl-2,4,6-trihydroxy-5-(3-methyl-2-buten-1-yl)phenyl]heptyl]-4-hydroxy-6-methyl-2H-pyran-2-one [ | + | + | |
| 28 | 3-[[3-acetyl-5-(3,7-dimethyl-2,6-octadienyl)-2,4,6-trihydroxyphenyl]methyl]-4-hydroxy-5-methyl-6-propyl-2H-pyran-2-one [ | + | ||
| 29 | 3-[[3-(3,7-dimethyl-2,6-octadien-1-yl)-2,4,6-trihydroxy-5-(2-methyl-1-oxobutyl)phenyl]methyl]-6-ethyl-4-hydroxy-5-methyl-2H-pyran-2-one [ | + | ||
| 30 | 3-[[3,7-dimethyl-2,6-octadien-1-yl]-2,4,6-trihydroxy-5-(2-methyl-1-oxobutyl)phenyl]methyl]-4-hydroxy-5,6-dimethyl-2H-pyran-2-one [ | + | + | |
| 31 | 3-[[2,3-dihydro-4,6-dihydroxy-2-(1-methylethenyl)-5-(2-methyl-1-oxobutyl)-7-benzofuranyl]methyl]-6-ethyl-4-hydroxy-5-methyl-2H-pyran-2-one [ | + | ||
|
| ||||
| 32 | 2’,3’-dihydroxypuberulin [ | + | ||
| 33 | 7-(2,3-dihydroxy-3-methylbutoxy)-5-hydroxy-6-methoxy-2H-1-benzopyran-2-one [ | + | + | |
| 34 | coumarin derivative [ | + | ||
| 35 | 7-(2,3-dihydroxy-3-methylbutoxy)-5,6-dimethoxy-2H-1-benzopyran-2-one [ | + | ||
| 36 | 2,3-dihydro-10-methoxy-2-(1-methylethenyl)-7H-pyrano[2,3-g]-1,4-benzodioxin-7-one [ | + | ||
|
| ||||
| 37 | 2-methoxy-3,5-dimethyl-6-(1-methylethyl)-4H-pyran-4-one [ | + | ||
| 38 | 3-[[2,4-dihydroxy-6-methoxy-3-(3-methyl-2-buten-1-yl)-5-(2-methyl-1-oxobutyl)phenyl]methyl]-6-ethyl-2-methoxy-5-methyl-4H-pyran-4-one [ | + | ||
| 39 | italipyrone [ | + | ||
| 40 | italipyrone analog [ | + | ||
|
| ||||
| 41 | 3-(acetyloxy)-2,3-dihydro-5,7-dihydroxy-6-(3-methyl-2-butenyl)-2-phenyl-4H-1-benzopyran-4-one [ | + | ||
| 42 | 2,3-dihydro-5,7-dihydroxy-3-methyl-8-(3-methyl-2-butenyl)-2-(1-methylethyl)-4H-1-benzopyran-4-one [ | + | ||
|
| ||||
|
| ||||
| 43 | apigenin-7- | + | ||
| 44 | apigenin-5- | + | ||
| 45 | luteolin [ | + | ||
| 46 | 3,5,6,7,8-pentamethoxyflavone [ | + | ||
| 47 | 3’,4’,5,6,7-pentamethoxyflavone [ | + | ||
| 48 | apigenin [ | + | ||
| 49 | dihydroxy-dimethoxyflavone [ | + | ||
| 50 | jaceosidin [ | + | ||
| 51 | chrysoeriol [ | + | ||
| 52 | 5,7-dihydroxy-3-methoxyflavone [ | + | ||
| 53 | 5,7,4’-trihydroxy-3,6-dimethoxy-3’-prenylflavone [ | + | ||
| 54 | TEDMF 1 [ | + | ||
| 55 | TEDMF [ | + | ||
| 56 | 6-[(6-ethyl-4-hydroxy-5-methyl-2-oxo-2H-pyran-3-yl)methyl]-2,3-dihydro-5,7-dihydroxy-8-(3-methyl-2-buten-1-yl)-2-phenyl-4H-1-benzopyran-4-one [ | + | ||
| 57 | TEDMF [ | + | ||
|
| ||||
| 58 | naringenin-5- | + | ||
| 59 | naringenin-4′- | + | ||
| 60 | naringenin-7- | + | ||
| 61 | eriodictyol [ | + | ||
| 62 | naringenin [ | + | + | |
|
| ||||
| 63 | quercetin-3- | + | ||
| 64 | kaempferol-3- | + | ||
| 65 | helichrysoside [ | + | ||
| 66 | quercetin [ | + | + | |
| 67 | tiliroside [ | + | ||
| 68 | tiliroside analog [ | + | ||
| 69 | kaempferol [ | + | ||
|
| ||||
| 70 | arenariumoside V [ | + | ||
| 71 | tomoroside A [ | + | ||
| 72 | isosalipurposide [ | + | ||
| 73 | helilupolone [ | + | ||
|
| ||||
|
| ||||
| 74 | sesquiterpene derivative [ | + | ||
| 75 | sesquiterpene derivative [ | + | ||
| 76 | sesquiterpene derivative [ | + | ||
| 77 | sesquiterpene derivative [ | + | ||
| 78 | sesquiterpene derivative [ | + | ||
| 79 | eudesmane derivative [ | + | ||
| 80 | sesquiterpene derivative [ | + | ||
| 81 | sesquiterpene derivative [ | + | ||
| 82 | ainsliaside E [ | + | ||
| 83 | cinnamoyloxy-hydroxyeudesmane [ | + | ||
| 84 | athrolide C [ | + | + | |
| 85 | athrolide D [ | + | ||
|
| ||||
| 86 | diterpene derivative [ | + | ||
| 87 | 8-(acetyloxy)-3-ethenyloctahydro-10-hydroxy-3,4a,7,7,10a-pentamethyl-1H-naphtho[2,1-b]pyran-2,5(3H,4aH)-dione [ | + | ||
| 88 | (7-ethenyl-1,2,3,4,4a,4b,5,6,7,8,10,10a-dodecahydro-1,4a,7-trimethyl-1-phenanthrenyl)methyl-butanedioic acid methyl ester [ | + | ||
| 89 | + | |||
| 90 | gymnospermin [ | + | ||
| 91 | diterpene derivative [ | + | ||
| 92 | + | |||
| 93 | 5-(acetyloxy)-α-ethenyldecahydro-α,3a,5,7b-tetramethyl-1H-cyclopropa[a]naphthalene-4-propanol acetate [ | + | ||
| 94 | + | + | ||
|
| ||||
| 95 | 4-[3,5-dihydroxy-4-(1-oxobutyl)phenoxy]-2-methyl-butanoic acid [ | + | ||
| 96 | 2,3-dihydro-4,5-dimethoxy-2,2-dimethyl-6-benzofuranol [ | + | ||
| 97 | 4,5-dimethoxy-6-(2-methyl-1-propen-1-yl)-1,3-benzenediol-1,3-diacetate [ | + | ||
| 98 | 1-(4,6-dihydroxy-2,3-dimethoxyphenyl)-2-methyl-1-butanone [ | + | ||
| 99 | 4-[3,5-dihydroxy-4-(2-methyl-1-oxopropyl)phenoxy]-2-methyl-2-butenoic acid methyl ester [ | + | ||
| 100 | acylphloroglucinol derivative [ | + | + | |
| 101 | 2-methyl-1-[2,4,6-trihydroxy-3-(3-methyl-2-buten-1-yl)phenyl]-1-propanone [ | + | ||
| 102 | [3,4-dihydro-5,7-dihydroxy-2-(4-methyl-3-penten-1-yl)-2H-1-benzopyran-6-yl]phenyl-methanone [ | + | + | |
| 103 | 2-(3,7-dimethyl-2,6-octadienyl)-3-hydroxy-5-methoxy-6-(2-methyl-1-oxopropyl)-2,5-cyclohexadiene-1,4-dione [ | + | ||
| 104 | phenyl[2,4,6-trihydroxy-3-(3-methyl-2-buten-1-yl)phenyl]-methanone [ | + | ||
| 105 | 1-[2,3-dihydro-4,6-dihydroxy-2-(1-methylethenyl)-5-benzofuranyl]-2-methyl-1-propanone [ | + | ||
| 106 | 7-acetyl-5’-ethyl-4,6-dihydroxy-4’-methyl-5-(3-methyl-2-buten-1-yl)-spiro[benzofuran-2(3H),2’(3’H)-furan]-3’-one [ | + | + | |
| 107 | 1-[2,6-bis(acetyloxy)-4-[[4-(acetyloxy)-3-[(acetyloxy)methyl]-2-buten-1-yl]oxy]phenyl]-1-butanone [ | + | + | |
| 108 | 4,6-dihydroxy-4’,5’-dimethyl-5-(3-methyl-2-buten-1-yl)-7-(2-methyl-1-oxobutyl)-spiro[benzofuran-2(3H),2’(3’H)-furan]-3’-one [ | + | ||
| 109 | 2-methyl-1-[2,4,6-trihydroxy-5-[(1S)-1-(4-hydroxy-6-methoxy-1,3-benzodioxol-5-yl)-2-methylpropyl]-3-(3-methyl-2-butenyl)phenyl]-1-propanone [ | + | ||
|
| ||||
| 110 | 7-( | + | ||
| 111 | 5,7-dihydroxyphthalide [ | + | + | |
| 112 | 7-( | + | ||
| 113 | 5-methoxy-7-hydroxyphthalide [ | + | + | |
| 114 | 4-(4-hydroxy-3-methylbutyl)-5,7-dimethoxy-1(3H)-isobenzofuranone [ | + | ||
|
| ||||
| 115 | chlorogenic acid [ | + | ||
| 116 | caffeic acid [ | + | ||
| 117 | everlastoside M [ | + | ||
| 118 | syringic acid [ | + | ||
| 119 | 3’,4’-methylenedioxycinnamic acid [ | + | ||
| 120 | di- | + | ||
| 121 | di- | + | ||
| 122 | 4-(3-methoxy-3-oxo-1-propen-1-yl)-2-(3-methyl-2-buten-1-yl)phenyl-3-(acetyloxy)-butanoic acid ester [ | + | ||
|
| ||||
| 123 | 4’-hydroxy-3’-(3-methyl-2-butenyl)-acetophenone [ | + | ||
| 124 | 1-[2-[1-[(acetyloxy)methyl]ethenyl]-2,3-dihydro-3-hydroxy-5-benzofuranyl]ethanone [ | + | + | |
|
| ||||
| 125 | inositol [ | + | ||
| 126 | quinic acid [ | + | ||
| 127 | 1,6-dihydroxy-4-oxo-2-cyclohexene-1-acetic acid methyl ester [ | + | ||
| 128 | tetrahydrojacarone [ | + | ||
| 129 | loliolide [ | + | ||
| 130 | 2-[4-(1,3-dihydroxypropyl)-2-methoxyphenoxy]-3-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-1-propanone [ | + | ||
| 131 | pinellic acid [ | + | + | |
| 132 | (3,4,5,6,7-pentamethoxy-2-benzofuranyl)phenylmethanone [ | + | ||
| 133 | PUFA 2 [ | + | ||
| 134 | pinoresinol [ | + | ||
| 135 | PUFA [ | + | ||
| 136 | dihydro-5-(5,8-tetradecadienyl)-2(3H)-furanone [ | + | ||
| 137 | PUFA [ | + | + | |
| 138 | hexadecanal [ | + | ||
|
| ||||
| 139 | 4-hydroxy-3,5-dimethyl-6-(1-methylethyl)-2H-pyran-2-one [ | + | ||
| 140 | 3-prenyl-2,4,6-trihydroxyacetophenone [ | + | + | |
| 141 | helinivene A [ | + | ||
| 142 | + |
1 triethoxy-dimethoxy-flavone; 2 polyunsaturated fatty acid; 3 presumed compounds for one formula which belongs to different classes are listed as unclassified.
Figure 1Phenolic representatives of H. plicatum: (a) naringenin (flavanone), (b) isosalipurposide (chalcone), (c) chlorogenic acid (phenolic acid ester), (d) 5,7-dihydroxyphthalide (phthalide), (e) plicatipyrone (chromanyl α-pyrone).
DPPH free radical scavenging activities of H. plicatum ethanol (EE), dichloromethane (DCME), acetonitrile oil (ACNE), and oil extracts (OE); BHT—butylated hydroxytoluene.
| EE | DCME | ACNE | OE | Trolox | BHT (Methanol) | BHT (Toluene) | |
|---|---|---|---|---|---|---|---|
| EC50 1 (mg/mL) | 0.45 ± 0.04 | 0.58 ± 0.02 | 1.74 ± 0.01 | 17.61 ± 0.16 | 0.064 ± 0.01 | 0.33 ± 0.01 | 1.42 ± 0.01 |
1 Data are presented as mean ± standard deviation (n = 3).
Antibacterial activity of H. plicatum ethanol (EE), dichloromethane (DCME), and acetonitrile oil (ACNE) extract against Gram-negative bacteria.
|
|
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| MIC | MBC | MIC | MBC | MIC | MBC | MIC | MBC | MIC | MBC | |
| mg/mL | mg/mL | mg/mL | mg/mL | mg/mL | ||||||
| EE | 2.5 | >10 | 0.625 | 2.5 | 2.5 | >10 | 1.25 | 5 | 2.5 | 5 |
| DCME | 0.313 | 2.5 |
| 0.625 | 0.157 | 0.625 | 0.157 | 0.625 | 1.25 | 10 |
| ACNE | 0.625 | 2.5 | 1.25 | 5 | 1.25 | 5 | 0.625 | 1.25 | 1.25 | 5 |
| Chloramphenicol | 0.062 | 0.25 | 0.125 | 0.062 | 0.125 | |||||
1 MIC value lower than the control.
Antibacterial activity of H. plicatum ethanol (EE), dichloromethane (DCME), and acetonitrile oil (ACNE) extract against Gram-positive bacteria.
|
|
|
| ||||
|---|---|---|---|---|---|---|
| MIC | MBC | MIC | MBC | MIC | MBC | |
| mg/mL | mg/mL | mg/mL | ||||
| EE | 0.313 | 2.5 | 0.313 | 1.25 | 2.5 | 10 |
| DCME | 0.157 | 0.625 | 0.157 | 0.625 | 0.313 | 1.25 |
| ACNE | 0.625 | 5 | 2.5 | 10 | 2.5 | 10 |
| Chloramphenicol | 0.015 | 0.015 | 0.25 | |||
Antifungal activity of H. plicatum ethanol (EE), dichloromethane (DCME), and acetonitrile oil (ACNE) extract.
|
|
|
| ||||
|---|---|---|---|---|---|---|
| MIC | MFC | MIC | MFC | MIC | MFC | |
| mg/mL | mg/mL | mg/mL | ||||
| EE |
| >10 | 1.25 | 10 | 2.5 | 5 |
| DCME |
| 2.5 | 1.25 | 5 |
| 2.5 |
| ACNE |
| 10 | 1.25 | 10 | 2.5 | 5 |
| Nystatin | 2.5 | 1.25 | 2.5 | |||
1 MIC values lower than the control are bolded.
Figure 2Structures of arzanol (left) and methylarzanol (right).